- idUS
- Listar por autor
Listar por autor "Márquez Malaver, Francisco J."
Mostrando ítems 1-3 de 3
-
Artículo
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score
Falantes, José F.; García Delgado, Regina; Calderón Cabrera, Cristina; Márquez Malaver, Francisco J.; Valcárcel, D.; De Miguel, Dunia; Bailén, Alicia; Bargay, Joan; Bernal, Teresa; González Porras, José R.; Tormo, Mar; Ramos, Fernando; Andreu, Rafael; Xicoy, Blanca; Nomdedeu, Benet; Brunet, Salut; Sánchez, Joaquín; Fernández Jurado, Antonio; Bonabad, Santiago; Pérez Simón, José Antonio; Sanz, Guillermo (Elsevier, 2015)Scoring systems for lower-risk myelodysplastic syndrome (LR-MDS) recognize patients with a poorer than expected outcome. ...
-
Artículo
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
Escamilla Gómez, Virginia; García-Gutiérrez, Valentín; López Corral, Lucía; García Cadenas, Irene; Pérez Martínez, Ariadna; Márquez Malaver, Francisco J.; Caballero Velázquez, Teresa; Espigado Tocino, Ildefonso; Pérez Simón, José Antonio (Springer Nature, 2020)Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. ...
-
Artículo
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate
Pérez Simón, José Antonio; Martino, Rodrigo; Parody, Rocío; Cabrero, Mónica; López Corral, Lucía; Valcárcel, D.; Martínez, Carmen; Solano, Carlos; Vázquez, Lourdes; Márquez Malaver, Francisco J.; Sierra, Jordi; Caballero, Dolores (Ferrata Storti Foundation, 2013)Different types of graft-versus-host disease prophylaxis have been proposed in the setting of reduced intensity and ...